NUSCA, ANNUNZIATA
 Distribuzione geografica
Continente #
AS - Asia 4.997
NA - Nord America 1.009
EU - Europa 529
OC - Oceania 35
SA - Sud America 34
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.619
Nazione #
SG - Singapore 4.423
US - Stati Uniti d'America 979
CN - Cina 353
IT - Italia 152
HK - Hong Kong 139
DE - Germania 76
GB - Regno Unito 76
NL - Olanda 56
EE - Estonia 46
CZ - Repubblica Ceca 42
AU - Australia 35
BR - Brasile 29
IN - India 26
CA - Canada 19
VN - Vietnam 17
FI - Finlandia 16
FR - Francia 12
MX - Messico 8
BE - Belgio 7
JP - Giappone 7
SE - Svezia 7
ZA - Sudafrica 7
ID - Indonesia 6
IR - Iran 6
AT - Austria 5
ES - Italia 5
TR - Turchia 5
CH - Svizzera 4
MA - Marocco 4
PL - Polonia 4
RO - Romania 4
UA - Ucraina 4
LT - Lituania 3
PK - Pakistan 3
RU - Federazione Russa 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
LU - Lussemburgo 2
NO - Norvegia 2
AL - Albania 1
BH - Bahrain 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
MY - Malesia 1
NI - Nicaragua 1
PE - Perù 1
RE - Reunion 1
RS - Serbia 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.619
Città #
Ashburn 418
Singapore 220
Dallas 148
Hefei 138
Hong Kong 136
Boardman 89
Rome 80
Beijing 75
London 57
Tallinn 45
Amsterdam 42
Munich 37
Shanghai 37
Council Bluffs 36
Brno 31
Los Angeles 30
Perth 22
San Francisco 20
Seattle 14
Washington 14
Brooklyn 11
Santa Clara 11
West Jordan 10
Milan 9
Olomouc 9
Bengaluru 8
Helsinki 8
São Paulo 8
Chennai 7
Tokyo 7
Turku 7
Bocholt 6
Hanover 6
Jinan 6
Montreal 6
Pune 6
The Dalles 6
Xi'an 6
Bologna 5
Zhengzhou 5
Chicago 4
Guangzhou 4
Ho Chi Minh City 4
Melbourne 4
Mexico City 4
New York 4
Nuremberg 4
San Jose 4
Stockholm 4
Târgu Mureş 4
Atlanta 3
Aubin Grove 3
Borås 3
Boston 3
Casablanca 3
Conroe 3
Frankfurt am Main 3
Hanoi 3
Johannesburg 3
Qingdao 3
Seichamps 3
Stuttgart 3
Taipei 3
Aberdeen 2
Ankara 2
Aversa 2
Basel 2
Calgary 2
Canberra 2
Castagnole 2
Central 2
Centurion 2
Ciampino 2
Durham 2
Florence 2
Gold Coast 2
Hamar 2
Hilo 2
Krakow 2
Liaocheng 2
Louisville 2
Luxembourg 2
Mainz 2
Manchester 2
North Bergen 2
Oklahoma City 2
Palermo 2
Quận Ninh Kiều 2
Rio de Janeiro 2
Santiago De Compostela 2
Shenyang 2
Shijiazhuang 2
Sona 2
Springfield 2
Suzhou 2
Thrissur 2
Toronto 2
Vienna 2
Warsaw 2
Xiamen 2
Totale 1.989
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 412
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 214
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 213
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 203
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 203
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 202
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 199
Changes of the Coronary Arteries and Cardiac Microvasculature With Aging: Implications for Translational Research and Clinical Practice 198
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 195
[The hybrid strategy for complete myocardial revascularization in the frail elderly patient]. 195
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 193
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 188
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 187
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 186
Dexamethasone-eluting stents attenuate endothelial activation in patients with unstable coronary syndromes 184
Current management and prognosis of patients with recurrent myocardial infarction 183
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 179
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: an unusual case of myocardial rupture 176
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 171
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 157
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 143
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 103
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 101
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 99
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 95
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 95
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 93
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 92
Correlation between glycemic variability assessed by CGM and short-term outcome in patients undergoing percutaneous coronary intervention 90
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 89
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 87
Glycemic variability in the development of cardiovascular complications in diabetes 86
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 85
Incidence, diagnosis, and prognosis of myocarditis: does gender matter? 82
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 81
Invasive Assessment of Coronary Microvascular Function 77
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 72
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 71
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 70
Classification of Aortic Stenosis Patients via ECG-Independent Multi-Site Measurements of Cardiac-Induced Accelerations and Angular Velocities at the Skin Level 60
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 49
Eosinophilic Myocarditis: From Bench to Bedside 42
Instantaneous wave-free ratio-guided revascularization of non-culprit lesion in patients with ST-segment elevation myocardial infarction and multivessel coronary disease: design and rationale of the WAVE Registry 42
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 40
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 34
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 33
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 33
Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking 31
Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures 30
Indirect respiratory monitoring via single-lead wearable ECG: Influence of motion artifacts and devices on respiratory rate estimations 30
Who is the next for aortic valve implantation? Present and future indications 30
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 29
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 28
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease 27
Double anterograde/retrograde approach for embolization of pulmonary arteriovenous malformation presenting with acute respiratory failure 25
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness 25
Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions 25
Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention 25
Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets 24
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 24
Functional Mitral and Tricuspid Regurgitation across the Whole Spectrum of Left Ventricular Ejection Fraction: Recognizing the Elephant in the Room of Heart Failure 23
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 22
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy 22
Protection from procedural myocardial injury by pre-treatment with atorvastatin is associated with lower expression of adhesion molecules after percutaneous coronary intervention 22
Novel Computed Tomography Variables for Assessing Tricuspid Valve Morphology: Results from the TRIMA (Tricuspid Regurgitation IMAging) Study 17
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review 17
Role of polypill in cardiovascular prevention and treatment 15
The Role of Cardiac Troponin and Other Emerging Biomarkers Among Athletes and Beyond: Underlying Mechanisms, Differential Diagnosis, and Guide for Interpretation 15
Cardiac involvement of Gorlin-Goltz syndrome: new light among the shadows of an old congenital disorder 14
Single-territory incomplete surgical revascularization improves regional wall motion of remote ventricular areas: results from a propensity-matched study. 14
Platelet function and markers of atherothrombotic risk in subjects with parathyroid disorders: a cross-sectional study 13
Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention 12
Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials. 12
The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure 10
Sodium-Glucose Transporter-2 Inhibitors (SGLT2i) and Myocardial Ischemia: Another Compelling Reason to Consider These Agents Regardless of Diabetes 10
Totale 6.673
Categoria #
all - tutte 28.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202262 0 0 2 0 2 0 0 0 0 0 9 49
2022/202394 2 1 16 11 13 2 0 2 1 0 46 0
2023/2024641 1 27 31 31 21 97 51 272 20 42 10 38
2024/20255.134 84 32 90 96 33 84 73 17 141 285 2.009 2.190
2025/2026742 253 153 198 138 0 0 0 0 0 0 0 0
Totale 6.673